These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30227356)

  • 101. Metabolic Pattern of Systemic Sclerosis: Association of Changes in Plasma Concentrations of Amino Acid-Related Compounds With Disease Presentation.
    Smolenska Z; Zabielska-Kaczorowska M; Wojteczek A; Kutryb-Zajac B; Zdrojewski Z
    Front Mol Biosci; 2020; 7():585161. PubMed ID: 33195431
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Individual variability in human urinary metabolites identifies age-related, body mass index-related, and sex-related biomarkers.
    Wang T; Tang L; Lin R; He D; Wu Y; Zhang Y; Yang P; He J
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1738. PubMed ID: 34293245
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Schizophrenia shows a unique metabolomics signature in plasma.
    He Y; Yu Z; Giegling I; Xie L; Hartmann AM; Prehn C; Adamski J; Kahn R; Li Y; Illig T; Wang-Sattler R; Rujescu D
    Transl Psychiatry; 2012 Aug; 2(8):e149. PubMed ID: 22892715
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Urinary acylcarnitines are altered in human kidney cancer.
    Ganti S; Taylor SL; Kim K; Hoppel CL; Guo L; Yang J; Evans C; Weiss RH
    Int J Cancer; 2012 Jun; 130(12):2791-800. PubMed ID: 21732340
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate.
    Slavik M; Lovenberg W; Keiser HR
    Biochem Pharmacol; 1973 Jun; 22(11):1295-300. PubMed ID: 4727783
    [No Abstract]   [Full Text] [Related]  

  • 106. Analysis of acylcarnitines in normal human urine with the radioisotopic exchange-high performance liquid chromatography (HPLC) method.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL
    Clin Chim Acta; 1989 May; 181(2):231-8. PubMed ID: 2736787
    [No Abstract]   [Full Text] [Related]  

  • 107. Metabolomics in systemic sclerosis.
    Gogulska Z; Smolenska Z; Turyn J; Zdrojewski Z; Chmielewski M
    Rheumatol Int; 2024 Oct; 44(10):1813-1822. PubMed ID: 38981905
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Probiotic
    Nessim Kostandy E; Suh JH; Tian X; Okeugo B; Rubin E; Shirai S; Luo M; Taylor CM; Kim KH; Rhoads JM; Liu Y
    Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398835
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Metabolic fingerprinting of systemic sclerosis: a systematic review.
    Morales-González V; Galeano-Sánchez D; Covaleda-Vargas JE; Rodriguez Y; Monsalve DM; Pardo-Rodriguez D; Cala MP; Acosta-Ampudia Y; Ramírez-Santana C
    Front Mol Biosci; 2023; 10():1215039. PubMed ID: 37614441
    [No Abstract]   [Full Text] [Related]  

  • 110. Perivascular adipose tissue in autoimmune rheumatic diseases.
    Shi H; Wu H; Winkler MA; Belin de Chantemèle EJ; Lee R; Kim HW; Weintraub NL
    Pharmacol Res; 2022 Aug; 182():106354. PubMed ID: 35842184
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Plasma Metabolomic Profiling Reveals Four Possibly Disrupted Mechanisms in Systemic Sclerosis.
    Bögl T; Mlynek F; Himmelsbach M; Sepp N; Buchberger W; Geroldinger-Simić M
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327409
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Lipid Alterations in Systemic Sclerosis.
    Gogulska Z; Smolenska Z; Turyn J; Mika A; Zdrojewski Z
    Front Mol Biosci; 2021; 8():761721. PubMed ID: 34993231
    [No Abstract]   [Full Text] [Related]  

  • 113. Identification of Urine Metabolic Biomarkers for Vogt-Koyanagi-Harada Disease.
    Chang R; Zhu Y; Xu J; Chen L; Su G; Kijlstra A; Yang P
    Front Cell Dev Biol; 2021; 9():637489. PubMed ID: 33718374
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease.
    Meier C; Freiburghaus K; Bovet C; Schniering J; Allanore Y; Distler O; Nakas C; Maurer B
    Sci Rep; 2020 Dec; 10(1):21912. PubMed ID: 33318574
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
    Beretta L; Barturen G; Vigone B; Bellocchi C; Hunzelmann N; De Langhe E; Cervera R; Gerosa M; Kovács L; Ortega Castro R; Almeida I; Cornec D; Chizzolini C; Pers JO; Makowska Z; Lesche R; Kerick M; Alarcón-Riquelme ME; Martin J; ;
    Ann Rheum Dis; 2020 Sep; 79(9):1218-1226. PubMed ID: 32561607
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Fatty Acid and Carnitine Metabolism Are Dysregulated in Systemic Sclerosis Patients.
    Ottria A; Hoekstra AT; Zimmermann M; van der Kroef M; Vazirpanah N; Cossu M; Chouri E; Rossato M; Beretta L; Tieland RG; Wichers CGK; Stigter E; Gulersonmez C; Bonte-Mineur F; Berkers CR; Radstake TRDJ; Marut W
    Front Immunol; 2020; 11():822. PubMed ID: 32528464
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A Case Report of Switching from Specific Vendor-Based to R-Based Pipelines for Untargeted LC-MS Metabolomics.
    Fernández-Ochoa Á; Quirantes-Piné R; Borrás-Linares I; Cádiz-Gurrea ML; Precisesads Clinical Consortium ; Alarcón Riquelme ME; Brunius C; Segura-Carretero A
    Metabolites; 2020 Jan; 10(1):. PubMed ID: 31936230
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Metabolic Biomarkers In Midtrimester Maternal Plasma Can Accurately Predict Adverse Pregnancy Outcome in Patients with SLE.
    Lee SM; Lee EM; Park JK; Jeon HS; Oh S; Hong S; Jung YM; Kim BJ; Kim SM; Norwitz ER; Lee EB; Louangsenlath S; Park CW; Jun JK; Park JS; Lee DY
    Sci Rep; 2019 Oct; 9(1):15169. PubMed ID: 31645572
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.